Suven Pharmaceuticals Limited (SUVENPHAR.NS)
INR 1222.2
(-1.95%)
INR 1222.2
(-1.95%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.67 Billion INR | -33.79% |
| 2022 | 6.2 Billion INR | -4.04% |
| 2021 | 6.74 Billion INR | 26.45% |
| 2020 | 4.56 Billion INR | 14.28% |
| 2019 | 4 Billion INR | 158.6% |
| 2018 | 1.72 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 799.3 Million INR | -11.58% |
| 2023 Q4 | 733.43 Million INR | -7.73% |
| 2023 Q3 | 794.89 Million INR | -32.52% |
| 2023 Q1 | 1.77 Billion INR | -1.58% |
| 2023 Q2 | 1.17 Billion INR | -33.68% |
| 2023 FY | - INR | -33.79% |
| 2022 Q1 | 1.61 Billion INR | 62.44% |
| 2022 Q4 | 1.8 Billion INR | 13.01% |
| 2022 Q3 | 1.59 Billion INR | 44.14% |
| 2022 Q2 | 1.1 Billion INR | -31.57% |
| 2022 FY | - INR | -4.04% |
| 2021 Q1 | 1.44 Billion INR | 26.65% |
| 2021 Q2 | 1.44 Billion INR | 0.17% |
| 2021 Q4 | 996.77 Million INR | -60.24% |
| 2021 Q3 | 2.5 Billion INR | 73.76% |
| 2021 FY | - INR | 26.45% |
| 2020 Q3 | 1.58 Billion INR | 47.76% |
| 2020 FY | - INR | 14.28% |
| 2020 Q2 | 1.07 Billion INR | -16.03% |
| 2020 Q1 | 1.28 Billion INR | 27.5% |
| 2020 Q4 | 1.13 Billion INR | -28.47% |
| 2019 Q3 | 908.88 Million INR | -32.4% |
| 2019 Q4 | 1 Billion INR | 10.58% |
| 2019 FY | - INR | 158.6% |
| 2019 Q2 | 1.34 Billion INR | 9.96% |
| 2019 Q1 | 1.22 Billion INR | 0.89% |
| 2018 Q3 | 497.26 Million INR | 0.0% |
| 2018 Q4 | 1.21 Billion INR | 143.72% |
| 2018 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Sigachi Industries Limited | 883.39 Million INR | -429.454% |
| Ind-Swift Limited | 1.06 Billion INR | -339.145% |
| Bajaj HealthCare Limited | 406.23 Million INR | -1051.34% |
| Sakar Healthcare Limited | 393.26 Million INR | -1089.312% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 92.43% |
| Innova Captab Limited | 1.66 Billion INR | -180.354% |
| Divi's Laboratories Limited | 25.43 Billion INR | 81.608% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | -98.455% |
| Morepen Laboratories Limited | 1.72 Billion INR | -170.991% |
| Mankind Pharma Limited | 28.09 Billion INR | 83.352% |
| Sequent Scientific Limited | 549.8 Million INR | -750.706% |
| Wanbury Limited | 985.49 Million INR | -374.605% |
| Laurus Labs Limited | 8 Billion INR | 41.579% |
| Nectar Lifesciences Limited | 1.53 Billion INR | -204.585% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | 31.848% |
| Alembic Limited | 1.11 Billion INR | -318.975% |
| Hikal Limited | 2.69 Billion INR | -73.729% |
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | 51.364% |
| Neuland Laboratories Limited | 4.74 Billion INR | 1.495% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 49.895% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 58.768% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | -79.436% |
| Themis Medicare Limited | 562.6 Million INR | -731.341% |
| RPG Life Sciences Limited | 1.28 Billion INR | -264.977% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 91.681% |
| Lupin Limited | 36.96 Billion INR | 87.349% |
| Amrutanjan Health Care Limited | 681.59 Million INR | -586.21% |
| Wockhardt Limited | 1.08 Billion INR | -333.072% |
| Vaishali Pharma Limited | 31.71 Million INR | -14649.399% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | -19.639% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -1345.985% |
| Jubilant Pharmova Limited | 8 Billion INR | 41.579% |
| FDC Limited | 3.38 Billion INR | -38.159% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 94.702% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -1527.27% |
| Eris Lifesciences Limited | 6.98 Billion INR | 33.054% |
| Venus Remedies Limited | 711.8 Million INR | -557.091% |
| ZIM Laboratories Limited | 462.09 Million INR | -912.165% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -216.233% |
| Par Drugs and Chemicals Limited | 228.17 Million INR | -1949.831% |
| Caplin Point Laboratories Limited | 6.18 Billion INR | 24.364% |
| Shilpa Medicare Limited | 2.58 Billion INR | -80.727% |
| Albert David Limited | 1.04 Billion INR | -347.396% |
| Ajanta Pharma Limited | 12.56 Billion INR | 62.777% |
| Hester Biosciences Limited | 539.47 Million INR | -766.996% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 265.746% |
| Gufic Biosciences Limited | 1.48 Billion INR | -215.922% |
| Windlas Biotech Limited | 781.72 Million INR | -498.319% |
| Procter & Gamble Health Limited | 3.07 Billion INR | -52.133% |
| Aarey Drugs & Pharmaceuticals Limited | 45.16 Million INR | -10255.767% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -2573.5% |
| Granules India Limited | 8.6 Billion INR | 45.638% |
| Aarti Drugs Limited | 3.24 Billion INR | -43.974% |
| Bal Pharma Limited | 345.59 Million INR | -1253.383% |
| Alkem Laboratories Limited | 24.19 Billion INR | 80.669% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 96.62% |
| Lincoln Pharmaceuticals Limited | 1.34 Billion INR | -248.18% |
| Medicamen Biotech Limited | 245.66 Million INR | -1803.925% |
| Unichem Laboratories Limited | 742.35 Million INR | -530.046% |
| Bafna Pharmaceuticals Limited | 114.58 Million INR | -3981.916% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.99 Million INR | -35889.397% |
| Valiant Laboratories Limited | 12.73 Million INR | -36615.456% |
| Orchid Pharma Limited | 1.41 Billion INR | -229.57% |
| Medico Remedies Limited | 129.09 Million INR | -3523.082% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | 31.836% |
| Ipca Laboratories Limited | 13.29 Billion INR | 64.832% |
| Brooks Laboratories Limited | 41.72 Million INR | -11108.738% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -987.019% |
| Piramal Enterprises Limited | -3.86 Billion INR | 221.136% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 86.64% |
| NATCO Pharma Limited | 18.79 Billion INR | 75.115% |
| Suven Life Sciences Limited | -992.78 Million INR | 571.12% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 5753.755% |
| Strides Pharma Science Limited | 3.76 Billion INR | -24.239% |
| Indoco Remedies Limited | 2.64 Billion INR | -76.694% |
| Alpa Laboratories Limited | 229.96 Million INR | -1933.902% |
| Lasa Supergenerics Limited | -65.08 Million INR | 7286.819% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 225.344% |